# Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)

> **NCT00453063** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 426 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** mometasone furoate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00453063
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 426 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00453063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00453063, "Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00453063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*